Research and development expense [negated] General and administrative expense [negated] Other expense, by function [negated] Cash flows from (used in) operations before changes in working capital [total] Cash flows from (used in) operating activities [total] Cash flows from (used in) investing activities [total] Payments for share issue costs [negated] Payments of lease liabilities, classified as financing activities [negated] Cash flows from (used in) financing activities [total] Increase (decrease) in cash and cash equivalents [total] Reduction of issued capital [negated] Adjustments for unrealised foreign exchange losses (gains) [negated] Cash, cash equivalents and other current financial assets Cash, cash equivalents and other current financial assets [total] Share premiums and reserves Retained Earnings Excluding Profit Loss Equity Profit Loss Attributable To Owners Of Parent Operating income Operating income [total] Operating expenses Operating expenses [negatedtotal] Financial income/(loss) Adjustments for decrease [increase] in trade accounts receivable and prepaid expenses Research tax credit Prepaid income Adjustments for decrease [increase] in other operating receivables [excluding prepaid expenses] (Acquisitions)/disposals of property, plant and equipment (Acquisitions)/disposals of intangible assets (Acquisitions)/disposals of non-consolidated equity securities Other (acquisitions)/disposals Net financial income/(loss) proceeds Net amounts received for financing of tax credits Bank loan Changes in cash and cash equivalents Net result - member Amendment due to IFRIC Application Allocatio of free shares Distribution d'actions gratuites Changes in equity